Novo Nordisk plans quantum computing hub in Denmark
In plans aimed at revolutionising healthcare and other life sciences, Novo Holdings is investing DKK 1.4 billion (€188 million) in building a hub of start-ups focused on new technologies including quantum computing. Quantum computers, capable of making scientific calculations that would otherwise take most computers thousands of years, can potentially speed up the development of pharmaceuticals and other life sciences. Novo Holdings is the parent company of Europe's most valuable firm, Novo Nordisk, known for its weight-loss medication Wegovy and Ozempic, a diabetes drug. "Quantum technologies...